Moneycontrol PRO
LAMF
LAMF

Viswanath Pilla

Senior Assistant Editor, Moneycontrol News

Glenmark says specialty & innovative products to contribute 30% revenues by 2025

BUSINESS

Glenmark says specialty & innovative products to contribute 30% revenues by 2025

DoP invokes emergency powers to block stent makers from withdrawing products

BUSINESS

DoP invokes emergency powers to block stent makers from withdrawing products

NPPA allows Abbott Healthcare to withdraw its popular drug eluting stent

BUSINESS

NPPA allows Abbott Healthcare to withdraw its popular drug eluting stent

Cadila Healthcare enters pact with Pharm-Aid to produce Chickenpox vaccine in Russia

BUSINESS

Cadila Healthcare enters pact with Pharm-Aid to produce Chickenpox vaccine in Russia

Govt to come up with a universal health insurance soon, consultations on with stakeholders

BUSINESS

Govt to come up with a universal health insurance soon, consultations on with stakeholders

Biocon's Vizag API plant clears US FDA inspection, shares up

BUSINESS

Biocon's Vizag API plant clears US FDA inspection, shares up

Pharma weekly wrap: Pharma stocks gain on investor interest due to cheap valuations

BUSINESS

Pharma weekly wrap: Pharma stocks gain on investor interest due to cheap valuations

Timeline of Dr Reddy's regulatory issues and stock price movement

BUSINESS

Timeline of Dr Reddy's regulatory issues and stock price movement

Law to check unethical marketing practices in pharma faces delay due to legal tangle

BUSINESS

Law to check unethical marketing practices in pharma faces delay due to legal tangle

Biocon gets funding from JDRF to test oral insulin on type-1 diabetes patients

BUSINESS

Biocon gets funding from JDRF to test oral insulin on type-1 diabetes patients

No change in IPO plans: Aster DM Healthcare set to refile DRHP

BUSINESS

No change in IPO plans: Aster DM Healthcare set to refile DRHP

Dr Reddy's gets two USFDA observations for Srikakulam plant

BUSINESS

Dr Reddy's gets two USFDA observations for Srikakulam plant

Dishman Pharma gains 20% on US FDA nod to client's cancer drug

BUSINESS

Dishman Pharma gains 20% on US FDA nod to client's cancer drug

Sun Pharma seeks marketing approval from European regulator for psoriasis drug

BUSINESS

Sun Pharma seeks marketing approval from European regulator for psoriasis drug

RS passes HIV-AIDS bill to penalise discrimination, make treatment obligatory

HEALTH-TRENDS

RS passes HIV-AIDS bill to penalise discrimination, make treatment obligatory

'Even in US and Europe, we haven't seen such orchestrated action by pharma cos'

BUSINESS

'Even in US and Europe, we haven't seen such orchestrated action by pharma cos'

New e-platform to help India weed out substandard drugs

BUSINESS

New e-platform to help India weed out substandard drugs

Sun Pharma buys Bellus Health arm, gets rights to its experimental kidney drug

BUSINESS

Sun Pharma buys Bellus Health arm, gets rights to its experimental kidney drug

Lupin gets US regulator nod for generic oral contraceptive Minastrin 24 Fe

BUSINESS

Lupin gets US regulator nod for generic oral contraceptive Minastrin 24 Fe

Why Scott Gottlieb, the new US FDA chief, could be good news for Indian drug makers

BUSINESS

Why Scott Gottlieb, the new US FDA chief, could be good news for Indian drug makers

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347